Investment in research has led to advances in detection and treatment of cancer that are leading to earlier and more accurate diagnoses and more targeted treatments that often carry less side effects. I’m so pleased that guest blogger Joydeep Goswami from Thermo Fisher Scientific is able to offer greater insight into these advances and the importance of making sure broad populations have access to these exciting new tools. Read More–>>
By Joydeep Goswami
President, Clinical Next Generation Sequencing and Oncology
Thermo Fisher Scientific
